Humanigen (HGEN) Competitors

→ The Key to this $10 Trillion Tech Boom (From Porter & Company) (Ad)

$0.0002

0.00 (0.00%)

(As of 06/13/2024 ET)

Stock Analysis Chart Competitors Financials Headlines Insider Trades SEC Filings Trends

HGEN vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Humanigen stock or one of its competitors? The main competitors of Humanigen include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Humanigen vs.

Humanigen (NASDAQ:HGEN) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk.

: 180 Life Sciences has lower revenue, but higher earnings than Humanigen.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Humanigen $1.70M 0.01 -$70.73M N/A N/A
180 Life Sciences N/A N/A N/A N/A N/A
: 4.6% of Humanigen shares are owned by institutional investors. 21.7% of Humanigen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humanigen
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, 180 Life Sciences had 1 more articles in the media than Humanigen. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Humanigen. 180 Life Sciences' average media sentiment score of 1.89 beat Humanigen's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Company Overall Sentiment
Humanigen Neutral
180 Life Sciences Very Positive
: Company Net Margins Return on Equity Return on Assets
Humanigen N/A N/A N/A
180 Life Sciences N/A N/A N/A
: Humanigen received 23 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
Company Underperform Outperform
Humanigen Outperform Votes
23
57.50%
Underperform Votes
17
42.50%
180 Life Sciences N/A N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humanigen	$1.70M	0.01	-$70.73M	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humanigen	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
Humanigen	Neutral
180 Life Sciences	Very Positive

Company	Net Margins	Return on Equity	Return on Assets
Humanigen	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Company	Underperform	Outperform
Humanigen	Outperform Votes 23 57.50%	Underperform Votes 17 42.50%
180 Life Sciences	N/A	N/A

Summary

Humanigen beats 180 Life Sciences on 4 of the 6 factors compared between the two stocks.

Ad Porter & Company

How Biden has already won 2024

Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.

Click here to watch this now before it’s too late.

Get Humanigen News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HGEN vs. The Competition

Export to Excel

Metric	Humanigen	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	$24,000.00	$156.74M	$5.32B	$8.35B
Dividend Yield	N/A	3.43%	2.73%	4.06%
P/E Ratio	N/A	220.95	171.22	18.31
Price / Sales	0.01	17,607.34	2,269.67	73.96
Price / Cash	N/A	11.14	34.18	30.83
Price / Book	0.00	6.62	4.93	4.29
Net Income	-$70.73M	-$19.91M	$110.23M	$216.19M
7 Day Performance	N/A	0.26%	-0.38%	-0.62%
1 Month Performance	N/A	1.27%	0.11%	-0.55%
1 Year Performance	N/A	-2.34%	0.60%	2.39%

Humanigen Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars	$0.01 -11.6%	N/A	+15.5%	$0.00	N/A	4	Gap Up High Trading Volume
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars	$0.08 flat	N/A	N/A	$0.00	$352,864.00	2	Gap Up
DRTSW Alpha Tau Medical	0 of 5 stars	$0.25 flat	N/A	-37.1%	$0.00	N/A	121	Short Interest ↓
APLMW Apollomics	0 of 5 stars	$0.02 flat	N/A	-82.8%	$0.00	N/A	59	Short Interest ↑ Gap Up
ARTLW Artelo Biosciences	0 of 5 stars	$0.01 -23.7%	N/A	-88.1%	$0.00	N/A	6	Gap Down
BCDAW BioCardia	0 of 5 stars	$0.01 -42.0%	N/A	-96.2%	$0.00	$468,000.00	16	Gap Up
BCTXW BriaCell Therapeutics	0 of 5 stars	$0.45 -5.1%	N/A	-85.0%	$0.00	N/A	16	Short Interest ↑ News Coverage
CDIOW Cardio Diagnostics	0 of 5 stars	$0.04 +34.7%	N/A	-67.8%	$0.00	$32,993.00	7	Short Interest ↓ Gap Down High Trading Volume
CTCXW Carmell	0 of 5 stars	$0.09 flat	N/A	N/A	$0.00	$3.73M	9	Gap Down High Trading Volume
SAVAW Cassava Sciences	0 of 5 stars	$0.03 flat	N/A	N/A	$0.00	N/A	29	Gap Up